SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-22-041929
Filing Date
2022-02-14
Accepted
2022-02-14 16:36:14
Documents
2
Group Members
CHART WESTCOTTNEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d286060dsc13ga.htm SC 13G/A 79047
2 EX-99.1 d286060dex991.htm EX-99.1 4765
  Complete submission text file 0001193125-22-041929.txt   85594
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Subject) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90212 | Film No.: 22633227
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A